Related Experiment Video
Updated: May 12, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Focussing of the clot: normal and pathologic mechanisms
Abstract:
Several physiologic antithrombotic mechanisms operate to prevent clot formation under normal circumstances and to focus the clot on the site of damage upon vascular injury. These mechanisms, which involve prostacyclin (PGI2), antithrombin III, protein C, and the fibrinolytic system, are interrelated, are activated by thrombin generation, and are dependent upon the integrity of normal endothelium surrounding the focus of injury. Acquired or inherited abnormalities in each of these physiologic antithrombotic systems have been linked to clinical bleeding and thrombotic disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction

